BDP1 mRNA expression was significantly decreased in ovarian cancer, p = 0.01 (Figure 2A) but the expression of other TFIIIB subunits, BRF1 (Figure 2B), BRF2 (Figure 2C), and TBP (Figure 2D), was not significantly changed. This evidence concerns the gene BRF2 and ovarian carcinoma.